AnaptysBio, Inc. (ANAB) Balance Sheet

NASDAQ: ANABAssets, liabilities, debt and equity over 10 years.

ANAB balance sheet, 2025

December 31, 2025 · U.S. dollars

$364.4M assets = $327.2M liabilities + $37.2M equity

What it owns$364.4MCash & ST investments: $311.6M (85.5%)Cash & ST investments$311.6M · 86%Receivables: $33.9M (9.3%)Receivables $33.9MOther current: $4.8M (1.3%)PP&E: $13.9M (3.8%)Other non-current: $256,000 (0.1%)=How it is financed$364.4MCurrent liabilities: $38.6M (10.6%)Current liabilities $38.6MOther LT liabilities: $288.6M (79.2%)Other LT liabilities$288.6M · 79%Shareholders’ equity: $37.2M (10.2%)$37.2M

Both columns are drawn to the same scale: what ANAB owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ANAB financial health

Current ratio9.07
Comfortable · current assets cover current liabilities 9.07×
Debt / equity0.38
Low leverage · $0.38 of debt for each $1 of equity
Equity / assets10.2%
Thin equity · of assets funded by shareholders
Cash / debt2,208.3%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ANAB balance sheet trends, 2016–2025

AnaptysBio, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$62.2M2016$364.4M2025+21.7%/yr
Total liabilities$22.9M2016$327.2M2025+34.4%/yr
Shareholders’ equity$39.3M2016$37.2M2025−0.6%/yr
Cash & short-term investments$51.2M2016$311.6M2025+22.2%/yr
Total debt$13.8M2016$14.1M2025+0.2%/yr
Net cash (debt)$37.4M2016$297.5M2025+$260.1M
Working capital$52.5M2016$311.6M2025+$259.1M
Book value per share$15.552017$1.192025−27.5%/yr
Current ratio10.2020169.072025−1.13
Debt / equity0.3520160.382025+0.03
Shares outstanding19.8M201731.3M2025+5.9%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ANAB assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ANAB liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ANAB debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ANAB balance sheet

AnaptysBio, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$311.6M$385.4M$390.9M$441.2M$548.1M$393.7M$374.2M$427.1M$248.4M$51.2M
Cash & equivalents$238.2M$123.1M$36.0M$71.3M$495.7M$250.5M$171.0M$113.6M$81.2M$51.2M
Short-term investments$73.4M$262.3M$354.9M$369.9M$52.4M$143.2M$203.2M$313.5M$167.2M—
Receivables$33.9M$40.8M$6.9M$1.4M$876,000$0$0$174,000$1.6M$5.3M
Inventory$0$0$1$1$1$0$0$0$0$1
Other current assets$4.8M$5.7M$9.1M$4.5M$4.9M$2.9M$3.5M$7.0M$2.7M$1.6M
Total current assets$350.2M$431.9M$406.8M$447.2M$553.9M$396.6M$377.7M$434.2M$252.7M$58.2M
Property, plant & equipment (net)$13.9M$16.2M$18.3M$20.0M$21.8M$2.1M$1.6M$1.4M$665,000$471,000
Goodwill & intangible assets$0$0$0$0$0$0$0$0$0$0
Long-term investments$0$35.5M$27.0M$142.9M$67.1M$17.5M$54.3M$73.1M$75.9M$0
Other non-current assets$256,000$256,000$256,000$256,000$256,000$318,000$1.5M$208,000$106,000$3.5M
Total assets$364.4M$483.8M$452.4M$610.4M$643.1M$416.6M$435.2M$509.0M$329.4M$62.2M
Liabilities
Accounts payable$3.9M$4.0M$4.7M$2.8M$1.7M$4.2M$16.2M$5.4M$2.3M$2.3M
Short-term debt$2.1M$1.9M$1.8M$1.6M$1.5M$342,000$2.2M$7.6M$6.9M$1,000
Deferred revenue——————$10.2M$8.7M$4.9M$3.4M
Total current liabilities$38.6M$45.4M$37.4M$26.1M$16.1M$19.8M$29.5M$21.8M$14.1M$5.7M
Long-term debt$0$0$0$0$0$0$0$625,000$7.6M$13.8M
Lease obligations$14.1M$16.0M$17.8M$19.4M$21.0M$342,000$871,000$58,000$17,000—
Other long-term liabilities$288.6M$367.5M$326.8M$322.2M$270.5M$4.6M$654,000$171,000$140,000$3.4M
Total liabilities$327.2M$413.0M$364.3M$348.3M$286.6M$19.8M$30.2M$22.6M$21.8M$22.9M
Shareholders' equity
Common stock & paid-in capital$28,000$30,000$27,000$29,000$28,000$27,000$27,000$27,000$24,000$3,000
Retained earnings (deficit)−$772.6M−$759.3M−$614.1M−$450.5M−$321.8M−$264.0M−$244.0M−$146.7M−$85.0M−$54.9M
Treasury stock————————$0—
Accumulated other comprehensive income−$24,000$305,000−$797,000−$5.2M−$422,000−$4,000$338,000−$223,000−$426,000−$3.8M
Minority interest————————$0—
Total shareholders' equity$37.2M$70.9M$88.1M$262.1M$356.4M$396.7M$405.0M$486.4M$307.6M$39.3M
Key figures
Total debt$14.1M$369.5M$17.8M$19.4M$21.0M$342,000$2.9M$8.3M$14.4M$13.8M
Net cash (debt)$297.5M$15.9M$373.1M$421.8M$527.1M$393.3M$371.3M$418.8M$234.0M$37.4M
Working capital$311.6M$386.4M$369.4M$421.2M$537.8M$376.7M$348.2M$412.4M$238.6M$52.5M
Tangible book value$37.2M$70.9M$88.1M$262.1M$356.4M$396.7M$405.0M$486.4M$307.6M$39.3M
Book value per share$1.19$2.50$3.27$9.31$12.99$14.53$14.97$19.71$15.55—
Shares outstanding31.3M28.4M26.9M28.2M27.4M27.3M27.1M24.7M19.8M—
Current ratio9.079.5110.8717.1634.4020.0112.7919.8917.9310.20
Quick ratio8.949.3810.6216.9934.1019.8612.6719.5717.749.91
Debt / equity0.385.210.200.070.060.000.010.020.050.35
Equity / assets10.2%14.6%19.5%42.9%55.4%95.2%93.1%95.6%93.4%63.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 3, 2026); data from EODHD.

ANAB financial position

At the end of fiscal 2025 (December 31, 2025), AnaptysBio had total assets of $364.4 million (down 24.7% from a year earlier), total liabilities of $327.2 million and shareholders' equity of $37.2 million. It held $311.6 million in cash and short-term investments against $14.1 million of debt, a net cash position of $297.5 million. Its current ratio was 9.07. In the latest quarter (ended June 30, 2026) total assets were $317.0 million and equity $10.6 million.

Related: ANAB income statement, ANAB cash flow statement, ANAB key metrics. See the ANAB stock overview for the latest quote and news.

ANAB balance sheet FAQ

What are AnaptysBio's total assets?

AnaptysBio reported total assets of $364.4 million at the end of fiscal 2025 (December 31, 2025), compared with $483.8 million a year earlier.

How much debt does AnaptysBio have?

AnaptysBio had $14.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.38.

How much cash does AnaptysBio have?

AnaptysBio held $311.6 million in cash and short-term investments at the end of fiscal 2025; with $14.1 million of debt that is net cash of $297.5 million.

What is AnaptysBio's book value?

AnaptysBio's shareholders' equity (book value) was $37.2 million at the end of fiscal 2025, or $1.19 per share.

What is AnaptysBio's current ratio?

AnaptysBio had current assets of $350.2 million and current liabilities of $38.6 million, a current ratio of 9.07 (it can cover its short-term obligations).

Biotechnology: balance sheet